Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enric Monreal

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis DiagnosisManuel Comabella, Agustín Pappolla, Enric Monreal, et al.
Brain : a Journal of Neurology|August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
Frontiers in Immunology|November 28, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Frontiers in Immunology|January 3, 2025
Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 24, 2026
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progressionAlvaro Cobo-Calvo, Juan Pablo Cuello, Enric Monreal, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis DiagnosisManuel Comabella, Agustín Pappolla, Enric Monreal, et al.
Brain : a Journal of Neurology|August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
Frontiers in Immunology|November 28, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Frontiers in Immunology|January 3, 2025
Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 24, 2026
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progressionAlvaro Cobo-Calvo, Juan Pablo Cuello, Enric Monreal, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
Pageof 6